NALMEFENE HCL
DEAD

Serial Number

97306650

Owner

Purdue Pharma L.P.

Attorney

Fara S. Sunderji

Filing Date

Mar 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NALMEFENE HCL Trademark

Serial Number: 97306650

NALMEFENE HCL is a trademark filed by Purdue Pharma L.P. on March 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Purdue Pharma L.P.

One Stamford Forum
Stamford, CT 06901

Entity Type: 13

Trademark Details

Filing Date

March 10, 2022

Registration Date

Not Registered

Published for Opposition

January 17, 2023

Goods & Services

Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 20, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 20, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 30, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jan 30, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 30, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Sep 11, 2025 EEXT
SOU EXTENSION 5 FILED
Sep 10, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2025 EXRA
SOU EXTENSION 4 GRANTED
Mar 5, 2025 EX4G
SOU EXTENSION 4 FILED
Mar 5, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2024 EXRA
SOU EXTENSION 3 GRANTED
Sep 12, 2024 EX3G
SOU EXTENSION 3 FILED
Sep 12, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Mar 12, 2024 EX2G
SOU EXTENSION 2 FILED
Mar 12, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2023 EXRA
SOU EXTENSION 1 GRANTED
Sep 8, 2023 EX1G
SOU EXTENSION 1 FILED
Sep 8, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 8, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 14, 2022 GPRN
PRIORITY ACTION E-MAILED
Jun 14, 2022 GPRA
PRIORITY ACTION WRITTEN
Jun 14, 2022 CPRA
ASSIGNED TO EXAMINER
Jun 7, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 17, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2022 NWOS
NEW APPLICATION ENTERED
Mar 14, 2022 NWAP